CBO Raises Cost Projections of Orphan Drug Carveout from Medicare Price Negotiations
- October 24, 2025
The Congressional Budget Office (CBO) upped its cost estimate for a provision of the tax and spending reconciliation measure that broadened the exclusion from the Medicare drug price negotiation program of orphan drugs.
ARTICLE TAGS
You must be logged in to access this content.